NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









IRICoR

IRICoR

Montrealiricor.ca

Overview

IRICoR is a non-profit drug discovery and commercialization centre that accelerates the transformation of academic research into new therapies for oncology, immunology, and rare diseases.

Year Founded

2008

Portfolio Companies

3

Website

iricor.ca

Investments

IRICoR investments
CompanyDateStageLead
EpitopeaOct 2024VC RoundCo-investor
EpitopOct 2024VC RoundCo-investor
ExCellTheraAug 2020GrantCo-investor
ExCellTheraJun 2015AcceleratorCo-investor

Key People

Elizabeth Douville

President CEO

Mario Callejo

Vice President, Scientific Operations At IRICoR, Chief Operating Officer (COO)

Jean-Louis Brochu

Director, Intellectual Property And Communications

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMontreal
Year Founded2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.